Vertex Pharmaceuticals
VRTX
#134
Rank
A$185.53 B
Marketcap
$720.44
Share price
-3.77%
Change (1 day)
35.91%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$10.22 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are A$10.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$7.55 B21.37%
2022-12-31A$6.22 B35.49%
2021-12-31A$4.59 B15.32%
2020-12-31A$3.98 B24.97%
2019-12-31A$3.18 B24.1%
2018-12-31A$2.57 B33.44%
2017-12-31A$1.92 B-10.92%
2016-12-31A$2.16 B12.12%
2015-12-31A$1.92 B27.44%
2014-12-31A$1.51 B40.22%
2013-12-31A$1.07 B-28.27%
2012-12-31A$1.50 B20.91%
2011-12-31A$1.24 B3.47%
2010-12-31A$1.20 B25.73%
2009-12-31A$0.95 B-9.01%
2008-12-31A$1.05 B178.33%
2007-12-31A$0.37 B-28.37%
2006-12-31A$0.52 B24.52%
2005-12-31A$0.42 B-35.75%
2004-12-31A$0.65 B-7.84%
2003-12-31A$0.71 B-7.83%
2002-12-31A$0.77 B-11.96%
2001-12-31A$0.88 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$54.73 B 435.34%๐Ÿ‡บ๐Ÿ‡ธ USA
A$212.48 B 1,978.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$112.88 B 1,004.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$118.29 B 1,057.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$167.27 B 1,536.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.38 B-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA